Clinical trial
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
NCT00218426 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00218426 |
|---|---|
| Title | Addiction Treatment in Russia: Oral vs. Naltrexone Implant |
| Official title | Addiction Treatment in Russia: Oral and Depot Naltrexone |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH St. Petersburg State Pavlov Medical University |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Heroin Dependence, Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | naltrexone implant, oral naltrexone, oral placebo naltrexone, placebo implant |
| Enrollment | 306 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Nov 4, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 18, 2019 |
| Countries | Russia, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: